Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.18+0.02 (+13.45%)
Close on Nov 13, 2026Market cap $137.15KP/E –Yield –
Endovia Health Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Endovia Health Sciences's total debt was $857 at Mar 31, 2026. For fiscal 2025 it was $3.42K, down 99.8% from the year before. Over ten years it grew -16.7% a year on average. The highest annual figure on record is $2.54M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.42K | -99.8% |
| FY2024 | Dec 31, 2024 | $1.97M | +330.7% |
| FY2023 | Dec 31, 2023 | $457.66K | -82.0% |
| FY2022 | Dec 31, 2022 | $2.54M | +745.4% |
| FY2021 | Dec 31, 2021 | $300.00K | -75.8% |
| FY2020 | Dec 31, 2020 | $1.24M | +14718.9% |
| FY2019 | Dec 31, 2019 | $8.37K | -61.9% |
| FY2018 | Dec 31, 2018 | $21.98K | -39.9% |
| FY2017 | Dec 31, 2017 | $36.60K | -22.4% |
| FY2016 | Dec 31, 2016 | $47.14K | +122.7% |
| FY2015 | Dec 31, 2015 | $21.17K | -40.9% |
| FY2014 | Dec 31, 2014 | $35.83K | +68.0% |
| FY2013 | Dec 31, 2013 | $21.32K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $857 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.42K | -99.8% |
| Q3 FY2025 | Sep 30, 2025 | $58.13K | -95.6% |
| Q2 FY2025 | Jun 30, 2025 | $52.53K | -96.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.08M | +157.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.97M | +330.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.32M | +223.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.43M | +505.3% |
| Q1 FY2024 | Mar 31, 2024 | $810.17K | -68.1% |
| Q4 FY2023 | Dec 31, 2023 | $457.66K | +84.2% |
| Q3 FY2023 | Sep 30, 2023 | $408.80K | +14.2% |
| Q2 FY2023 | Jun 30, 2023 | $236.66K | -21.1% |
| Q4 FY2022 | Dec 31, 2022 | $2.54M | +120.8% |
| Q3 FY2022 | Sep 30, 2022 | $248.43K | -79.6% |
| Q2 FY2022 | Jun 30, 2022 | $358.00K | -71.1% |
| Q4 FY2021 | Dec 31, 2021 | $300.00K | -75.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.15M | +1689.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.22M | +14429.2% |
| Q1 FY2021 | Mar 31, 2021 | $1.24M | +13409.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.24M | +9603.8% |
| Q2 FY2020 | Jun 30, 2020 | $64.20K | +289.0% |
| Q4 FY2019 | Dec 31, 2019 | $8.37K | -61.9% |
| Q3 FY2019 | Sep 30, 2019 | $9.18K | -65.8% |
| Q2 FY2019 | Jun 30, 2019 | $12.78K | -57.6% |
| Q1 FY2019 | Mar 31, 2019 | $16.50K | -50.3% |
| Q4 FY2018 | Dec 31, 2018 | $21.98K | -39.9% |
| Q3 FY2018 | Sep 30, 2018 | $26.87K | -31.2% |
| Q2 FY2018 | Jun 30, 2018 | $30.15K | -28.1% |
| Q1 FY2018 | Mar 31, 2018 | $33.21K | +47.5% |
| Q4 FY2017 | Dec 31, 2017 | $36.60K | -22.4% |
| Q3 FY2017 | Sep 30, 2017 | $39.04K | +39.1% |
| Q2 FY2017 | Jun 30, 2017 | $41.92K | +142.6% |
| Q1 FY2017 | Mar 31, 2017 | $22.52K | – |
| Q4 FY2016 | Dec 31, 2016 | $47.14K | – |
| Q3 FY2016 | Sep 30, 2016 | $28.07K | – |
| Q2 FY2016 | Jun 30, 2016 | $17.28K | – |
See a number that looks wrong?